Inari Medical Stock Current Valuation
| NARI Stock | USD 44.11 0.33 0.74% |
Valuation analysis of Inari Medical helps investors to measure Inari Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The current Enterprise Value Over EBITDA is estimated to decrease to 413.46. The current Enterprise Value Multiple is estimated to decrease to 413.46. Fundamental drivers impacting Inari Medical's valuation include:
Price Book 6.0644 | Enterprise Value 2.5 B | Enterprise Value Ebitda 1.6 K | Price Sales 4.6946 | Forward PE 208.3333 |
Undervalued
Today
Please note that Inari Medical's price fluctuation is very steady at this time. Calculation of the real value of Inari Medical is based on 3 months time horizon. Increasing Inari Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Inari Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Inari Stock. However, Inari Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 44.11 | Real 52.32 | Target 83.1 | Hype 43.88 | Naive 46.03 |
The intrinsic value of Inari Medical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Inari Medical's stock price.
Estimating the potential upside or downside of Inari Medical helps investors to forecast how Inari stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Inari Medical more accurately as focusing exclusively on Inari Medical's fundamentals will not take into account other important factors: Inari Medical Company Current Valuation Analysis
Inari Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Inari Medical Current Valuation | 2.49 B |
Most of Inari Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inari Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Inari Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Inari Medical is extremely important. It helps to project a fair market value of Inari Stock properly, considering its historical fundamentals such as Current Valuation. Since Inari Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Inari Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Inari Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Inari Current Valuation Historical Pattern
Today, most investors in Inari Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Inari Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Inari Medical current valuation as a starting point in their analysis.
Inari Medical Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Inari Medical has a Current Valuation of 2.49 B. This is 82.64% lower than that of the Health Care Equipment & Supplies sector and 79.93% lower than that of the Health Care industry. The current valuation for all United States stocks is 85.0% higher than that of the company.
Inari Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Inari Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Inari Medical could also be used in its relative valuation, which is a method of valuing Inari Medical by comparing valuation metrics of similar companies.Inari Medical is currently under evaluation in current valuation category among its peers.
Inari Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Inari Medical from analyzing Inari Medical's financial statements. These drivers represent accounts that assess Inari Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Inari Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 2.0B | 2.8B | 4.5B | 3.4B | 3.7B | 2.4B | |
| Enterprise Value | 2.0B | 2.7B | 4.5B | 3.3B | 3.7B | 2.4B |
Inari Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Inari Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Inari Medical's managers, analysts, and investors.Environmental | Governance | Social |
Inari Fundamentals
| Return On Equity | -0.13 | ||||
| Return On Asset | -0.0215 | ||||
| Profit Margin | (0.10) % | ||||
| Operating Margin | (0.11) % | ||||
| Current Valuation | 2.49 B | ||||
| Shares Outstanding | 58.27 M | ||||
| Shares Owned By Insiders | 8.87 % | ||||
| Shares Owned By Institutions | 93.60 % | ||||
| Number Of Shares Shorted | 4.25 M | ||||
| Price To Earning | 275.35 X | ||||
| Price To Book | 6.06 X | ||||
| Price To Sales | 4.69 X | ||||
| Revenue | 493.63 M | ||||
| Gross Profit | 338.96 M | ||||
| EBITDA | 7.11 M | ||||
| Net Income | (1.64 M) | ||||
| Cash And Equivalents | 330.5 M | ||||
| Cash Per Share | 6.19 X | ||||
| Total Debt | 32.05 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 10.04 X | ||||
| Book Value Per Share | 7.29 X | ||||
| Cash Flow From Operations | 35.93 M | ||||
| Short Ratio | 4.70 X | ||||
| Earnings Per Share | (0.99) X | ||||
| Price To Earnings To Growth | (1.88) X | ||||
| Target Price | 64.5 | ||||
| Number Of Employees | 1.3 K | ||||
| Beta | 1.0 | ||||
| Market Capitalization | 2.57 B | ||||
| Total Asset | 674.24 M | ||||
| Retained Earnings | (48.49 M) | ||||
| Working Capital | 159.22 M | ||||
| Net Asset | 674.24 M |
About Inari Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Inari Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inari Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inari Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| MSFT | Microsoft | |
| V | Visa Class A | |
| MSFT | Microsoft | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Inari Medical Piotroski F Score and Inari Medical Altman Z Score analysis. For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari Medical. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.84) | Earnings Share (0.99) | Revenue Per Share 9.472 | Quarterly Revenue Growth 0.225 | Return On Assets (0.02) |
The market value of Inari Medical is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari Medical's value that differs from its market value or its book value, called intrinsic value, which is Inari Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari Medical's market value can be influenced by many factors that don't directly affect Inari Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inari Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inari Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.